Many hyperprolactinaemic women would like to fall pregnant and, since the administration of bromocriptine lowers the prolactin levels. and restores gonadal function, conception presents little difficulty. there are, however, several important considerations that must be recognised by both physician and patient, including the possible teratogenic sequelae of foetal exposure to bromocriptine.
There is no evidence for teratogenicity in animal studies, and in one thousand four hundred women who were taking bromocriptine when they conceived, there is no evidence of increased incidence of abortion, multiple pregnancy, or foetal abnormalities. Until these babies have lived their own complete life cycles, however, the possibility of unexpected late effects cannot be excluded.
